Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MED-route study of intravenous versus subcutaneous rHuEPO in dialysis patients
ChiCTR1900022297Phase 4Not yet recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of erythropoietin in anemia of chronic kidney disease (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Hemoglobin concentration, Reticulocyte count and 5 more. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
erythropoietin
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on ChiCTR1900022297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022297.